Cann Group Ltd
CAN
Company Profile
Business description
Cann Group Ltd is an Australia-based company engaged in the cultivation, manufacture, and supply of medicinal cannabis products for medicinal and research purposes. The company offers dried cannabis flower, oils, and other medicinal cannabis products. It also develops and manufactures finished product formulations through third-party arrangements. Geographically, the company generates revenue from Australia, the United Kingdom, and New Zealand, with the majority of its revenue generated from Australia.
Contact
23 Greentek Court
KoorlongVIC3501
AUST: +61 390957088
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
40
Stocks News & Analysis
stocks
Chip stock selloff deepens in Asia, extends to Europe and US
The week’s tech stock rout continues despite strong earnings from TSMC and ASML.
stocks
Downgrade for ASX listed fund manager as redemptions pile on
Persistent outflows erode earnings outlook.
stocks
Tesla stock is down nearly 20% this year. Is it a buy ahead of earnings?
Following the rollout of its first autonomous Cybercab, here’s what we expect from Tesla’s earnings report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,932.00 | 91.60 | 1.04% |
| CAC 40 | 7,934.70 | 61.59 | 0.78% |
| DAX 40 | 25,382.62 | 84.01 | 0.33% |
| Dow JONES (US) | 52,177.69 | 556.21 | 1.08% |
| FTSE 100 | 10,840.35 | 115.49 | 1.08% |
| HKSE | 24,371.66 | 308.94 | 1.28% |
| NASDAQ | 26,713.03 | 20.16 | 0.08% |
| Nikkei 225 | 65,550.68 | 1,124.73 | 1.75% |
| NZX 50 Index | 13,757.92 | 74.88 | -0.54% |
| S&P 500 | 7,744.06 | 25.12 | 0.33% |
| S&P/ASX 200 | 8,798.30 | 78.60 | 0.90% |
| SSE Composite Index | 3,735.65 | 28.18 | 0.76% |